GPH-201(Graphite Bio)

N/A

Report date: 2025/08/21 17:31:01

Base Information

Drug NameGPH-201(Graphite Bio)
Drug Alias NameGPH-201
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionGene transferenceIL-2RG gene transference
TargetsInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsX-Linked Combined Immunodeficiency Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLenz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLenz Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsX-Linked Combined Immunodeficiency Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A